InnoCare Announces First Healthy Volunteer Dosed in Clinical Trial of Novel VAV1 Degrader ICP

BEIJING, March 15, 2026 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first healthy volunteer has been dosed in a clinical trial of ICP-538, a VAV1-directed molecular glue degrader (MGD), in China. This is the first VAV1 […]


play_arrow All Canada News
67 h.
Science
ID: 8430919926764784152


Similar News expand_more


1 M. InnoCare Announces IND Approval to Initiate Clinical Trial of VAV1 Degrader ICP
Technology
9 d. Junshi Biosciences Announces NMPA Acceptance of New Drug Applications for Toripalimab Injection (Subcutaneous) Across 12 Indications
Science
2 w. Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First
Science
2 w. Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology
Science
3 w. Junshi Biosciences Announces Strategic Collaboration with Antengene to Evaluate Combination Therapy with JS207 (PD
Science
1 M. Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Science
23 h. Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting
Science
3 w. Un médecin influenceur quitte CBS en raison de ses échanges avec Epstein
Science
1 M. Niagen Bioscience is the Premiere Sponsor of the Inaugural “NAD for Health: Opportunities & Challenges” Conference Hosted by the University of Copenhagen
Science
2 w. FDA approves HERNEXEOS®, the first targeted therapy for adults with HER2
Science
7 d. Io Therapeutics, Inc. announces publication of studies on the company’s RXR agonist compound IRX4204 for breast cancer prevention
Science
33 h. Knight Therapeutics Announces Approval of Additional Indication for MINJUVI® (tafasitamab) in Brazil
Science
4 w. Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens
Science
8 d. Early, regular intervention makes difference for kids sick with E. coli, U of C researchers find
Science
3 w. La clinique médicale l’Actuel, fondée par le Dr Réjean Thomas, en faillite
Science
7 d. Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States
Science
3 w. Oncotelic Therapeutics Inc. (OTCQB: OTLC) Announces Expanded IP Coverage, Strengthening Position in Biotech Evolution
Technology
1 w. Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th
Science
6 d. Cloudcure Launches Companion App to Close Clinical Adherence Gap in Metabolic Health
Science
3 w. Les IPS au sein d’un GMF pourront directement prendre des patients à leur charge
Science
3 w. Trois primes aux médecins pour un seul patient: les infirmières spécialisées sous
Science
1 w. The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
Science
1 w. Colby Cosh: The Canadian pediatric medicine researchers who ‘made it up’
Science
1 M. Fatality inquiry hears of link between deadly disorder and AstraZeneca COVID vaccine
Science
2 w. B.C. teen first in world to be cured of rare disease through gene editing treatment
Science
1 M. Ipsen delivers strong results in 2025, driven by solid execution across all therapeutic areas, and provides 2026 guidance
Technology
3 d. I tried the futuristic wellness treatment Toronto Raptors use and here's how it went
Science
1 M. Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease
Science
4 d. Pilot project adds new vehicles to Alberta Emergency Health Services' fleet
Automotive
20 h. Edmonton clinical trial offers hope to people suffering ‘most severe pains known to mankind’
Science
1 M. Synaptive Medical Announces Formation of Clinical Advisory Board Comprised of Global Surgical and Imaging Leaders
Science
1 M. Choisir le bon antibiotique plus rapidement à l’aide de la nanotechnologie
Science
2 w. Codetta Bio Announces Commercial Availability of Concerto™ System and New Customizable Cytokine and Neuroscience Panels at AGBT 2026
Science
5 d. Recommendations made following review into Edmonton emergency room death
Science
1 w. Study finds kidney disease, failure Toronto’s fastest growing chronic condition
Science
1 M. Nouveau service offert par le gouvernement: Airmedic met fin à son service de secours par hélicoptère après 25 ans
Military
3 w. Jeffrey Epstein a fait l'objet d'une enquête de l'agence américaine antidrogue
Science
3 w. Jeffrey Epstein a fait l’objet d’une enquête de l’agence américaine antidrogue
Science
4 w. Un vaccin développé au Québec pourrait protéger les enfants de trois maladies
Science
2 w. Un Canadien sur 10 prend de l’Ozempic: un médicament utilisé pour les mauvaises raisons, selon un médecin
Science
1 M. Brownstein: Maestro SVP targeted with antisemitic slur as it prepares to close
Science
1 M. «J’ai un patient diabétique qui avait arrêté ses traitements»: les conseils santé issus de l’IA inquiètent les médecins
Science
3 w. AI & Technology Virtual Investor Conference: Presentations Now Available for On
Technology
1 w. QS propose la création d’un service de première ligne dédié à la cyberviolence
Technology
1 M. Rappel national d’un médicament contre l’hypertension: ce que vous devez savoir
Science
2 w. Les médecins spécialistes promettent des moyens de pression sans effets sur les rendez
Science
2 w. Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high
Technology
1 w. Birchtech to Participate in the iAccess Alpha Virtual Best Ideas Spring Investment Conference
Technology
2 w. Lenovo Unveils Adaptive AI PCs, Modular Concepts, and Lenovo Qira Rollout at MWC 2026
Technology
Popular countries based on strong economic and political relations
Add Watch Country

arrow_drop_down